Updated:
Forge Life Science Partners
Forge Life Science Partners is a life-sciences-focused private equity firm based in Cambridge, MA, with no publicly named team members or portfolio...
Forge Life Science Partners
Forge Life Science Partners is a Massachusetts-based venture capital firm. It has made 7 investments, including a Series B investment in Kinaset Therapeutics on January 10, 2026. The firm has 2 portfolio exits, including IDRx on January 13, 2025.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Cambridge
Corporate office
Cambridge, MA, United States
Frequently asked questions
What is Forge Life Science Partners' investment strategy?
The firm's website structure labels its strategy sections as 'Venture (General)' targeting the life sciences sector. No specific asset classes, stage preferences, fund structures, or named investments are disclosed on its public pages, so the actual deployment posture cannot be confirmed.
Who runs Forge Life Science Partners?
No founders, managing partners, or investment professionals are named on the firm's website, its LinkedIn presence, or external public filings. The principals remain unknown.
Does Forge Life Science Partners disclose any portfolio companies or recent deals?
No. The Portfolio section of the website contains no company names, deal descriptions, or exit records, and no publicly sourced mentions of specific investments have been located.
Is Forge Life Science Partners structured as a single family office or a traditional private equity firm?
The firm self-reports as an asset manager and a private equity firm. No family office designation, multi-family structure, or wealth-origin narrative appears in any available public source, which distinguishes it from single-family-office vehicles.
Where is Forge Life Science Partners located, and does it operate in other geographies?
The sole disclosed location is Cambridge, Massachusetts, United States. No additional offices or international investment footprints are documented on its website or in other public materials.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: